Adriano Bonfim Carregaro I Gabrielle Coelho Freitas II Fernando Silvério Ferreira da Cruz II

The objective was to determine the cardiopulmonary effects and eyeball centralization time obtained with 15 or 30μg kg -1 of atracurium in anesthetized dogs under spontaneous breathing. Eighteen healthy adult mixed-breed dogs were used, which received 0.1mg kg -1 acepromazine and 0.5mg kg-1 morphine IM, followed by 4mg kg -1 propofol IV and maintained on isoflurane anesthesia with spontaneous breathing. Animals received 1mL 0.9% NaCl IV (CG), 15μg kg-1 (G15) or 30μg kg-1 (G30) of atracurium IV. Eyeball centralization time was measured; heart rate (HR), systolic (SAP), mean (MAP) and diastolic (DAP) arterial pressures, respiratory rate (RR), tidal volume (Vt) and minute volume (Vm) were determined every 5min, and pH, arterial CO2 pressure (PaCO2 ), arterial O2 pressure (PaO2 ), hemoglobin oxygen saturation (SaO2 ) , bicarbonate (HCO3 ) and base excess (BE) every 15min until 60min. Both doses of atracurium produced a similar period of eyeball centralization. Vt in groups treated with atracurium was lower than in CG up to 15min. Vm in G15 differed from CG up to 10min and in G30 up to 25min. No differences were observed for cardiovascular parameters, RR, SaO 2 , PaO 2 , HCO 3 - and BE. pH decreased in CG between 30 and 60min and in G15 and G30 at 15min. G30 differed from CG between 15 and 30min. PaCO 2 in GC differed from baseline between 30 and 60min and in G15 differed at 15min. Atracurium at the dose of 15μg kg -1 is adequate for short corneal procedures in inhalant-anesthetized dogs under spontaneous breathing.

[1]  A. Carregaro,et al.  Uso de atracúrio para o bloqueio da musculatura extrínseca do bulbo ocular em cães submetidos à anestesia inalatória sob ventilação espontânea , 2006 .

[2]  G. Murphy,et al.  Residual Neuromuscular Blockade: Incidence, Assessment, and Relevance in the Postoperative Period Anestesia Reviews , 2022 .

[3]  I. A. Gomez de Segura,et al.  Neuromuscular blocking properties of atracurium during sevoflurane or propofol anaesthesia in dogs. , 2005, Veterinary anaesthesia and analgesia.

[4]  E. Martinez Newer neuromuscular blockers. Is the practitioner ready for muscle relaxants? , 1999, The Veterinary clinics of North America. Small animal practice.

[5]  P. Hellyer,et al.  Respiratory depressant and skeletal muscle relaxant effects of low-dose pancuronium bromide in spontaneously breathing, isoflurane-anesthetized dogs. , 1998, Veterinary surgery : VS.

[6]  T. Glover,et al.  Surgery for cataracts. , 1997, The Veterinary clinics of North America. Small animal practice.

[7]  R. Nishimura,et al.  Cardiopulmonary effects of sevoflurane, compared with halothane, enflurane, and isoflurane, in dogs. , 1997, American Journal of Veterinary Research.

[8]  J. Thurmon,et al.  Lumb & Jones Veterinary Anesthesia , 1996 .

[9]  J. L. Jones Noninvasive monitoring techniques in anesthetized animals , 1996 .

[10]  P. Carli,et al.  Airway management and ventilation: a statement for the advanced life support working party of the European Resuscitation Council , 1992 .

[11]  S. Haskins Monitoring and Support , 1992 .

[12]  J. Jantzen,et al.  Cardiovascular effects of vecuronium, atracurium, pancuronium, metocurine and RGH‐420 1 in dogs , 1989, Acta anaesthesiologica Scandinavica.

[13]  S. Robertson Simple acid-base disorders. , 1989, The Veterinary clinics of North America. Small animal practice.

[14]  Y. Ohta,et al.  The Influence of Respiratory‐induced Acid‐base Changes on the Action of Non‐depolarizing Muscle Relaxants in Rats , 1988, Anesthesiology.

[15]  J. Stenlake,et al.  In vitro degradation of atracurium in human plasma. , 1987, British journal of anaesthesia.

[16]  W. D. Kaehny Respiratory acid-base disorders. , 1983, The Medical clinics of North America.

[17]  R. Hughes,et al.  The pharmacology of atracurium: a new competitive neuromuscular blocking agent. , 1981, British journal of anaesthesia.